Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123M
-
Number of holders
-
1077
-
Total 13F shares, excl. options
-
101M
-
Shares change
-
+3.37M
-
Total reported value, excl. options
-
$13.8B
-
Value change
-
+$444M
-
Put/Call ratio
-
0.67
-
Number of buys
-
470
-
Number of sells
-
-506
-
Price
-
$136.47
Significant Holders of CLOROX CO /DE/ - Common Stock (CLX) as of Q2 2024
1,249 filings reported holding CLX - CLOROX CO /DE/ - Common Stock as of Q2 2024.
CLOROX CO /DE/ - Common Stock (CLX) has 1,077 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101M shares
of 123M outstanding shares and own 82.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.3M shares), BlackRock Inc. (10.9M shares), STATE STREET CORP (7.94M shares), GEODE CAPITAL MANAGEMENT, LLC (2.99M shares), CITADEL ADVISORS LLC (2.83M shares), MORGAN STANLEY (2.45M shares), STIFEL FINANCIAL CORP (2.3M shares), Royal Bank of Canada (1.66M shares), NUANCE INVESTMENTS, LLC (1.6M shares), and Champlain Investment Partners, LLC (1.56M shares).
This table shows the top 1077 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.